Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04240951
Other study ID # PEP-1714
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 21, 2017
Est. completion date October 24, 2020

Study information

Verified date March 2021
Source PepsiCo Global R&D
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine the validity of a prototype patch in measuring sweating rate and sweat electrolyte concentration during moderate intensity exercise against well-established reference methods in a controlled laboratory and in field conditions.


Recruitment information / eligibility

Status Completed
Enrollment 552
Est. completion date October 24, 2020
Est. primary completion date October 24, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years to 45 Years
Eligibility Inclusion Criteria: - Subject is male or female - Subject is 15-45 years - Subject is moderately-trained (engages in moderate-intensity, intermittent, or steady-state exercise at least 4 days per week for at least 1 hour at a time) - Subject is capable of moderate-intensity, intermittent exercise for 1-2 hours as assessed by recent training history - If participating in Study Session 1, 2, 3, or 4, subject has a treadmill VO2max = 42 ml/kg/min if male or = 38 ml/kg/min if female, as measured during the screening at the GSSI laboratory - If participating in Study Session 1, 2, 3, or 4, subject has a normal fasting blood glucose (70-110 mg/dl), as measured during the screening at the GSSI laboratory - If participating in Study Session 1, 2, 3, or 4, subject has a normal resting blood pressure (< 140/90 mmHg), as measured during the screening at the GSSI laboratory - If participating in Study Session 1, 2, 3, or 4, subject has a normal resting and graded exercise EKG, as measured during the screening at the GSSI laboratory - If participating in Study Session 1, 2, 3, or 4, willing to be shaved at patch sites - If participating in Study Session 3 or 4, willing to undergo a nude shower by an investigator of the same sex for collection of sweat electrolytes in the whole body wash procedure - If participating in Study Session 5 or 6, subject is a trained team-sport athlete currently participating in training/competition at IMG Academy Exclusion Criteria: - Subject is pregnant (self-reported) - Subject is a smoker - Subject has a body weight that is lighter than 80 pounds - Subject has a known or suspected obstructive disease of the gastrointestinal tract, such as diverticulitis or inflammatory bowel disease - Subject has a history of problems with the gag reflex - Subject has not had previous gastrointestinal surgery - Subject has problems with swallowing - Subject is planning to have an MRI scan during the time that the CorTemp™ Core Body Temperature Sensor is in the body - Subject has slow movement of the gastrointestinal tract - Subject has a cardiac pacemaker or other implanted electronic device - Subject has asthma or other condition in which breathing can become difficult/labored during exercise (applies to Study Session 1-4 only) - Subject is allergic to adhesives - Subject is currently taking a medication or oral supplement that could interfere with study results - Subject has a condition the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk - Subject has been enrolled into a PepsiCo-sponsored study within the past six months - Subject has been enrolled into a clinical trial at a laboratory or clinic other than PepsiCo within the past 30 days - Subject is employed by, or has a parent, guardian or other immediate family member employed by, a company that manufactures any products that compete with any Gatorade products. If subject is unsure if a company would be considered a competitor to Gatorade they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Sweat patch
Flexible, epidermal, wearable skin patch to collect and analyze sweat

Locations

Country Name City State
United States Gatorade Sports Science Institute (GSSI) Barrington Illinois
United States Gatorade Sports Science Institute at IMG Academy Bradenton Florida

Sponsors (1)

Lead Sponsor Collaborator
PepsiCo Global R&D

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sweat chloride concentration Prototype vs. reference method (regional absorbent patch technique) during exercise 1.5 hours in sessions 1-6
Secondary Regional sweating rate Prototype vs. reference method (gravimetry using the regional absorbent patch technique) during exercise 1.5 hours in sessions 1-6
Secondary Whole body sweating rate Prototype vs. reference method (changes in nude body mass corrected for fluid intake, urine output, respiratory water loss, and metabolic mass loss) during exercise 1.5 hours in sessions 1-6
Secondary Whole body sweat chloride concentration Prototype vs. reference method (whole body washdown technique) during exercise 1.5 hours in sessions 3-4
Secondary Whole body sweat sodium concentration Reference method only. Compare whole body sweat chloride concentration vs. whole body sweat sodium concentration during exercise 1.5 hours in sessions 3-4
Secondary Self-ratings of perceived sweating vs. measured sweating rate Multiple choice questionnaire vs. sweat patch analysis Prior to the start of exercise at sessions 1-6
Secondary Self-ratings of perceived sweat saltiness vs. sweat electrolyte concentrations Multiple choice questionnaire vs. sweat patch analysis Prior to the start of exercise at sessions 1-6
Secondary History of exercise-associated muscle cramps Multiple choice questionnaire Prior to the start of exercise at sessions 1-6
See also
  Status Clinical Trial Phase
Completed NCT04679532 - NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players N/A